Shares of AbbVie Inc. ABBV, +2.94% slid 1.02% to $145.27 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +2.24% rising 1.50% to 4,288.70 and the Dow Jones Industrial Average DJIA, +2.51% rising 0.28% to 33,223.83. The stock’s fall snapped a two-day winning streak. AbbVie Inc. closed $3.08 short of its 52-week high ($148.35), which the company achieved on February 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Pfizer Inc. PFE, +3.83% fell 1.94% to $45.96, Eli Lilly & Co. LLY, +3.20% rose 2.00% to $243.08, and AstraZeneca PLC ADR AZN, +4.21% fell 2.39% to $58.13. Trading volume (12.1 M) eclipsed its 50-day average volume of 8.0 M.